Abstract: An optical device includes an LED chip, a light absorber and/or visible-light luminescent material, and a near-infrared luminescent material, wherein a luminous power of light emitted by the near-infrared luminescent material and the light absorber and/or visible-light luminescent material in a band of 650-1000 nm under the excitation of the LED chip is A, and a sum of a luminous power of light emitted by the near-infrared and visible-light luminescent materials in a band of 350-650 nm under the excitation of the LED chip and a luminous power of residual light emitted by the LED chip in the band of 350-650 nm after the LED chip excites the near-infrared and visible-light luminescent materials is B, with B/A*100% being 0.1%-10%. According to the implementation where the optical device employs the LED chip to combine the near-infrared luminescent material and the light absorber and/or visible-light luminescent material simultaneously.

Abstract: A bonding method and a bonding device for a flexible panel. In the process of bonding a protective cover plate and the flexible panel, a heated-type optical adhesive is used, the optical adhesive at normal temperature has relatively low viscosity and the viscosity thereof is below a bondable threshold, so that before the flexible panel and the edge of the protective cover plate are bonded, the optical adhesive and the edge of the protective cover plate come into contact in advance and then can be effectively separated, thus poor bonding in a bending region is avoided, the risk of generating bubbles and cracks is small, and the bonding yield can be improved. Moreover, the optical adhesive is increased in viscosity after heated, thereby ensuring that the flexible panel is bonded to the protective cover plate.

Abstract: The invention relates to a phosphor with garnet structure and a light-emitting device comprising the phosphor, wherein the phosphor includes the following components in percentage by weight: 38.47-45.19% of Y element, 9.49-22.09% of Al element, 2.06-24.31% of Ga element, 27.3-32.04% of O element, 0.43-1.46% of Ce element. In the phosphor particles, the shortest distance from the surface of one side of the particle to the surface of the opposite side through the centroid of the particle is defined as R, the longest distance is R1, and 5 ?m?R?40 ?m; any distance from the particle surface to the centroid is r, and 0<r<½R; and the space with the distance from the particle surface to the centroid direction being less than or equal to r is defined as rinner.

Abstract: An optical device includes an LED chip, a visible-light luminescent material, and a near-infrared luminescent material, wherein a luminous power of light emitted by the near-infrared and visible-light luminescent materials in a band of 650-1000 nm under the excitation of the LED chip is A, and a sum of a luminous power of light emitted by the near-infrared and visible-light luminescent materials in a band of 350-650 nm under the excitation of the LED chip and a luminous power of residual light emitted by the LED chip in the band of 350-650 nm after the LED chip excites the near-infrared and visible-light luminescent materials is B, with B/A*100% being 0.1%-10%. According to the implementation where the optical device employs the LED chip to combine the near-infrared luminescent material and the visible-light luminescent material simultaneously.

Abstract: The present disclosure provides an alkali metal-modified acoustic reinforcing material, a production method thereof, a speaker and an electronic device. The alkali metal-modified acoustic reinforcing material is prepared by homogeneously mixing an alkali metal-modified molecular sieve, a binder, a dispersant and an auxiliary agent and then shaping; wherein the content of the alkali metal-modified molecular sieve is not less than 70%, the content of alkali metal is 0.001-1.45%, the dry basis content of the dispersant is 0-1%, and the dry basis content of the auxiliary agent is 0-15%, based on 100% of the total weight of the alkali metal-modified acoustic reinforcing material.

Abstract: The present disclosure provides an iron-modified acoustic material, prepared by homogeneously mixing an iron-modified molecular sieve, a binder, a dispersant and an auxiliary agent and then shaping the mixture; wherein the content of the iron-modified molecular sieve is not less than 70%, the content of iron is 0.004-1.7%, the dry basis content of the dispersant is 0-1%, and the dry basis content of the auxiliary agent is 0-15%, based on 100% of the total weight of the iron-modified acoustic material. In the present disclosure, a molecular sieve is modified with an iron source to produce the iron-modified molecular sieve, and the iron-modified acoustic material is produced from the iron-modified molecular sieve as a raw material and provided in a rear cavity of a speaker, which can substantially improve its stability and reliability in terms of acoustic performance.

Abstract: The present disclosure provides a porous bulk material and an electronic apparatus thereof, and an apparatus capable of reducing wind noise and an application thereof. The apparatus comprises an external sound channel, a zeolite material, and a sound pickup hole, wherein the zeolite material is disposed between the external sound channel and the sound pickup hole. The present disclosure further provides an application of the apparatus in an electronic device provided with a microphone. According to the apparatus, the wind noise can be effectively reduced, and the call quality of a communication device is obviously improved.

Abstract: Provided in the present application are an acoustic reinforcing material block and an application thereof, a micro loudspeaker and an electronic device. The raw materials of the acoustic reinforcing material block include a porous material, an adhesive, and an adjuvant loaded in a structural framework. The micro loudspeaker comprises an upper housing and a lower housing which form an inner cavity, and a loudspeaker unit located in the inner cavity, wherein the inner cavity is divided into a front cavity and a rear cavity, and the front cavity is in communication with a sound outlet hole; and a front cavity resonant cavity which is in communication with the front cavity and filled with an acoustic enhancing material is provided in the upper housing.

Abstract: Provided are a hierarchical porous ZSM-5 molecular sieve and a preparation method therefor. The molecular sieve comprises micropores and mesopores, wherein the pore size of the micropores is 0.5-1.8 nm, the pore size of the mesopores is 4-30 nm, and the particle size is 0.3-4 ?m. The molecular sieve is prepared by using a hemicellulose as a hard template agent. Also provided are a hierarchical porous HZSM-5 molecular sieve, which is obtained by subjecting the ZSM-5 molecular sieve to ion exchange with an ammonium chloride solution, and the use of ZSM-5 and HZSM-5 molecular sieves in the preparation of a sound-absorbing material, the sound-absorbing material made from the molecular sieve, and a speaker loaded with the sound-absorbing material.

Abstract: The invention provides methods for the determination of insulin sensitivity, insulin resistance, and non-insulin dependent Diabetes mellitus based on oral glucose tolerance test data and lipid ratios from reference populations that define an insulin resistance index. The invention also provides methods for using the IR index to determine disease progression and to evaluate the efficacy of therapeutic agents. The invention further provides an IR calculator for automating diagnosis, producing and storing patient medical records.

Abstract: The invention provides a method for the determination of insulin sensitivity, insulin resistance, and non-insulin dependent Diabetes mellitus based on oral glucose tolerance test data and lipid ratios from reference populations that define an insulin resistance index. The invention also provides methods for using the IR index to determine disease progression and to evaluate the efficacy of the therapeutic agents. The invention further provides an IR calculator for automating diagnosis, producing and storing patient medical records.

Abstract: The invention relates to methods and biomarkers useful in screening subjects for insulin resistance and for monitoring insulin resistance over time or after medical intervention.

Abstract: The invention provides a method for the determination on of insulin sensitivity, insulin resistance, and non-insulin dependent Diabetes mellitus based on oral glucose tolerance test data and lipid ratios from reference populations that define an insulin resistance index he invention also provides m for using the IR index to determine disease progression and to evaluate the efficacy of the therapeutic agents. The invention further provides an IR calculator for automating diagnosis, producing and storing patient medical records.

Abstract: A single point mutation in the human lipoprotein lipase gene which results in an A→G nucleotide change at codon 291 (nucleotide 1127) of the lipoprotein lipase gene, and a substitution of serine for the normal asparagine in the lipoprotein lipase gene product is seen with increased frequency in patients with coronary artery disease, and is associated with an increased susceptibility to coronary artery disease, including in particular premature atherosclerosis. This is expressed as a diminished catalytic activity of lipoprotein lipase, lower HDL-cholesterol levels and higher triglyceride levels. Thus, susceptibility of a human individual to premature atherosclerosis can be evaluated by: (a) obtaining a sample of DNA from the individual; and (b) evaluating the sample of DNA for the presence of nucleotides encoding a serine residue as amino acid 291 of the lipoprotein lipase gene product. The presence of a serine residue is indicative of increased susceptibility in the patient.

Abstract: METHODS AND REAGENTS FOR DIAGNOSIS AND TREATMENT OF INSULIN RESISTANCE AND RELATED CONDITIONSMethods, reagents and devices for diagnosis, prognosis and treatment of insulin resistance and insulin resistance related conditions are provided.

Abstract: A single point mutation in the human lipoprotein lipase gene which results in an A.fwdarw.G nucleotide change at codon 291 (nucleotide 1127) of the lipoprotein lipase gene, and a substitution of serine for the normal asparagine in the lipoprotein lipase gene product is seen with increased frequency in patients with coronary artery disease, and is associated with an increased susceptibility to coronary artery disease, including in particular premature atherosclerosis. This is expressed as a diminished catalytic activity of lipoprotein lipase, lower HDL-cholesterol levels and higher triglyceride levels. Thus, susceptibility of a human individual to premature atherosclerosis and other forms of coronary artery disease can be evaluated byevaluating the sample of DNA for the presence of nucleotides encoding a serine residue as amino acid 291 of the lipoprotein lipase gene product. The presence of a serine residue is indicative of increased susceptibility in the patient.